Selective, high affinity A2B adenosine receptor antagonists: N-1 monosubstituted 8-(pyrazol-4-yl)xanthines
- 8 January 2008
- journal article
- research article
- Published by Elsevier in Bioorganic & Medicinal Chemistry Letters
- Vol. 18 (4) , 1397-1401
- https://doi.org/10.1016/j.bmcl.2008.01.008
Abstract
No abstract availableKeywords
This publication has 10 references indexed in Scilit:
- A2Badenosine receptor antagonists and their potential indicationsExpert Opinion on Therapeutic Patents, 2006
- Novel 1,3-Disubstituted 8-(1-benzyl-1H-pyrazol-4-yl) Xanthines: High Affinity and Selective A2BAdenosine Receptor AntagonistsJournal of Medicinal Chemistry, 2006
- Novel 1,3-dipropyl-8-(1-heteroarylmethyl-1H-pyrazol-4-yl)-xanthine derivatives as high affinity and selective A2B adenosine receptor antagonistsBioorganic & Medicinal Chemistry Letters, 2006
- The discovery of a selective, high affinity A2B adenosine receptor antagonist for the potential treatment of asthmaBioorganic & Medicinal Chemistry Letters, 2005
- Synergy between A2B Adenosine Receptors and Hypoxia in Activating Human Lung FibroblastsAmerican Journal of Respiratory Cell and Molecular Biology, 2005
- A2BAdenosine Receptors Increase Cytokine Release by Bronchial Smooth Muscle CellsAmerican Journal of Respiratory Cell and Molecular Biology, 2004
- 1,8-Disubstituted Xanthine Derivatives: Synthesis of Potent A2B-Selective Adenosine Receptor AntagonistsJournal of Medicinal Chemistry, 2002
- Molecular Modeling and Synthesis of Inhibitors of Herpes Simplex Virus Type 1 Uracil-DNA GlycosylaseJournal of Medicinal Chemistry, 1999
- Synthesis of paraxanthine analogs (1,7-disubstituted xanthines) and other xanthines unsubstituted at the 3-position: structure-activity relationships at adenosine receptorsJournal of Medicinal Chemistry, 1993
- General Synthesis and Properties of 1-Monosubstituted XanthinesSynthesis, 1993